Literature DB >> 12115556

Family history of breast cancer, age and benign breast disease.

Penelope M Webb1, Celia Byrne, Stuart J Schnitt, James L Connolly, Timothy Jacobs, Gloria Peiro, Walter Willett, Graham A Colditz.   

Abstract

A major risk factor for breast cancer is having a first-degree family history of the disease. Benign breast disease (BBD), particularly atypical hyperplasia, is also associated with an increased risk of breast cancer. However, the relationship between family history of breast cancer and BBD is unclear. From 1989 through 1997, 80,995 participants in the Nurses' Health Study II were followed; 16,849 reported a first diagnosis of BBD. Pathology slides were reviewed for 1,465 women who reported having a tissue biopsy, and these were classified as nonproliferative BBD, proliferative BBD without atypia or atypical hyperplasia. Women with a family history of breast cancer were more likely to report a physician diagnosis of BBD [rate ratio (RR) = 1.38, 95% confidence interval (CI) 1.29-1.46]. The magnitude of this association declined with age from RR = 1.96 (95% CI 1.55-2.47) at 25-29 years to RR = 1.20 (95% CI 0.95-1.52) at age 45-50 years. Among women with proliferative disease, those with a family history of breast cancer were almost 3 times as likely to have atypia (prevalence odds ratio = 2.72, 95% CI 1.23-5.89) than those with no family history. In conclusion, women with a family history of breast cancer appear to be at increased risk of being diagnosed with BBD, in particular the high-risk types of BBD associated with a greatly increased risk of breast cancer. This link adds weight to the belief that BBD with atypia is a precursor or marker lesion for breast cancer. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12115556     DOI: 10.1002/ijc.10490

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Use of clinical history affects accuracy of interpretive performance of screening mammography.

Authors:  Patricia A Carney; Andrea J Cook; Diana L Miglioretti; Stephen A Feig; Erin Aiello Bowles; Berta M Geller; Karla Kerlikowske; Mark Kettler; Tracy Onega; Joann G Elmore
Journal:  J Clin Epidemiol       Date:  2011-10-15       Impact factor: 6.437

2.  Young women with family history of breast cancer and their risk factors for benign breast disease.

Authors:  Catherine S Berkey; Rulla M Tamimi; Bernard Rosner; A Lindsay Frazier; Graham A Colditz
Journal:  Cancer       Date:  2011-11-14       Impact factor: 6.860

3.  Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.

Authors:  Rhonda Arthur; Yihong Wang; Kenny Ye; Andrew G Glass; Mindy Ginsberg; Olivier Loudig; Thomas Rohan
Journal:  Breast Cancer Res Treat       Date:  2017-06-22       Impact factor: 4.872

4.  Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.

Authors:  Meghan J Walker; Lucia Mirea; Kristine Cooper; Mitra Nabavi; Gord Glendon; Irene L Andrulis; Julia A Knight; Frances P O'Malley; Anna M Chiarelli
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

5.  Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium.

Authors:  Tehillah S Menes; Karla Kerlikowske; Shabnam Jaffer; Deborah Seger; Diana L Miglioretti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

6.  History of benign breast disease and risk of breast cancer among women in China: a case-control study.

Authors:  Tsogzolmaa Dorjgochoo; Sandra L Deming; Yu-Tang Gao; Wei Lu; Ying Zheng; Zhixian Ruan; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2008-03-18       Impact factor: 2.506

7.  DNA repair gene variants associated with benign breast disease in high cancer risk women.

Authors:  Timothy J Jorgensen; Kathy J Helzlsouer; Sandra C Clipp; Judy Hoffman Bolton; Rosa M Crum; Kala Visvanathan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

8.  Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factors.

Authors:  Andrea J Cook; Joann G Elmore; Diana L Miglioretti; Edward A Sickles; Erin J Aiello Bowles; Gary R Cutter; Patricia A Carney
Journal:  J Clin Epidemiol       Date:  2009-09-09       Impact factor: 6.437

9.  Thyroid nodules coexisting with either cystic or solid breast nodules: a new clue for this association between nodules coming from ultrasonography.

Authors:  Alessandro Sindoni; Fausto Fama'; Antonio Rosano'; Claudio Scisca; Gianlorenzo Dionigi; Christian A Koch; Maria Gioffrè-Florio; Salvatore Benvenga
Journal:  Gland Surg       Date:  2017-12

10.  Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer.

Authors:  Soley Bayraktar; Hongming Qiu; Diane Liu; Yu Shen; Angelica M Gutierrez-Barrera; Banu K Arun; Aysegul A Sahin
Journal:  Biomark Cancer       Date:  2015-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.